Bevacizumab and interferon reduce venous recanalization following sclerotherapy.
Kulungowski AM, Hassanein AH, Foster CC, Greene AK, Fishman SJ. Bevacizumab and interferon reduce venous recanalization following sclerotherapy. J Pediatr Surg. 2016 Oct; 51(10):1670-3.